Please check your internet connection and try again.
# Sodium Phosphate Enema
## Overview
Sodium phosphate enema is a hypertonic saline solution used for the evacuation of the lower bowel. It works by drawing water into the colon through osmotic pressure, which softens stool and stimulates bowel peristalsis.
## Primary Indications
* Bowel preparation for diagnostic procedures (e.g., sigmoidoscopy, colonoscopy).
* Bowel preparation for surgery.
* Treatment of occasional constipation.
## Adult Dosing
* **Bowel Preparation:** Typically, one 4.5 oz (133 mL) enema administered 3-5 hours prior to the procedure.
* **Constipation:** One 4.5 oz (133 mL) enema administered as a single dose. Do not use more than one enema in a 24-hour period.
## Pediatric Dosing
* **Ages 2-11 years:** One pediatric size enema (2.25 oz or 66 mL). Use with caution.
* **Under 2 years:** Contraindicated due to increased risk of hyperphosphatemia, hypocalcemia, and seizures.
## Dose Adjustments
No dose adjustments are typically required for renal or hepatic impairment due to minimal systemic absorption when used as directed. However, caution is advised in patients with pre-existing renal impairment.
## Contraindications
* Congestive heart failure
* Anuria
* Renal insufficiency
* Congenital or acquired megacolon
* Intestinal obstruction
* Appendicitis symptoms (nausea, vomiting, abdominal pain)
* Children under 2 years of age
* Patients with severely impaired renal function
* Patients on medications that may affect renal function or electrolyte balance (e.g., diuretics, ACE inhibitors, ARBs, NSAIDs).
* Patients with impaired gag reflex or at risk of aspiration.
## Adverse Effects
* **Common:** Abdominal cramping, bloating, nausea, vomiting, rectal irritation.
* **Serious:**
* **Electrolyte Disturbances:** Hyperphosphatemia, hypocalcemia, hypernatremia, hypokalemia. This is a significant risk, especially in children, the elderly, and those with renal impairment. Symptoms may include muscle twitching or cramps, numbness or tingling, irregular heartbeat, and seizures.
* **Renal Injury:** Acute kidney injury, particularly with repeated or excessive use, or in susceptible individuals.
* **Dehydration:** Due to fluid shifts.
* **Rectal perforation:** Though rare, can occur with forceful administration or in the presence of underlying bowel pathology.
## Key Drug Interactions
* **Diuretics, ACE inhibitors, ARBs, NSAIDs:** Concurrent use can increase the risk of hyperphosphatemia and renal impairment. Monitor electrolytes and renal function closely.
* **Medications affecting bowel motility:** May alter the effectiveness or increase the risk of adverse events.
## Monitoring
* Electrolytes (phosphate, calcium, sodium, potassium) and renal function (BUN, creatinine) are crucial, especially in at-risk populations (pediatrics, elderly, renal impairment, concurrent use of interacting medications).
* Monitor for signs and symptoms of electrolyte imbalance or dehydration.
## Clinical Pearls
* This product is a stimulant laxative and osmotic agent; it is not intended for long-term use.
* Administer slowly to minimize cramping and discomfort.
* Ensure adequate hydration before and after administration.
* Do not use in patients with undiagnosed abdominal pain, nausea, or vomiting.
* The risk of serious electrolyte disturbances and renal injury is significant, especially in pediatric patients and those with underlying risk factors. Consider alternative agents if risk is high.
* Use the smallest effective dose.
* Do not use in children under 2 years of age due to severe risks.
***
**Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and local institutional protocols for complete and up-to-date guidance.
